Success Story

Noblegen

10/27/2016
Noblegen is an advanced bioproducts manufacturer dedicated to developing competitively priced, naturally-derived biomaterials and biochemicals for market applications.

In a world facing the increasing impact of climate change, there is a huge demand for sustainable and scalable solutions. Young entrepreneur and renowned scientist Adam Noble founded Noblegen Inc. (formerly Noble Purification) to address these great challenges and help redefine the relationship between people and the planet.

Noblegen is an advanced bioproducts manufacturer dedicated to developing competitively priced, naturally-derived biomaterials and biochemicals for market applications that range from food and beverage ingredients to water purification and biopharmaceuticals. The company uses a proprietary approach to grow naturally occurring microorganisms for their valuable compounds. The results are sustainable, efficient and cost-effective bioproducts that offer innovative alternatives to existing, often synthetic, products.

Noblegen’s patented “directed expression” technique forms the core of the company’s multi-product platform. The technology originated in research Noble undertook at Trent University, which won him several national and international awards. In 2013, he co-founded Noblegen with Dr. Andressa Lacerda to apply the research to solving the industrial challenge of wastewater pollution.

OCE supported Noblegen in the company’s early stages, helping the company take its water purification technology from a science fair project to a full-scale demonstration. In 2014, a Voucher for Innovation and Productivity (VIP) project validated the feasibility of the system. Market Readiness support allowed Noblegen to demonstrate its technology in a full-scale pilot project.

Following Market Readiness support, Noblegen attracted significant follow-on investment and expanded the applications of its technology from wastewater to health, nutrition and biochemicals. The company is building a $20-million production facility in Peterborough scheduled to open in 2017.

Return on Innovation

  • Noblegen has raised $5.5 million in follow-on investment
  • The company currently has 17 full-time employees and projects, adding 10 jobs in 2017
  • OCE Investment: $140,729

OCE©2016 Last updated 10/2016